FDA Advisory Committee: Premature Labor Drug Makena Should Be Withdrawn
SILVER SPRING, Md. — The premature labor drug Makena took a step closer to being pulled off the market with a vote to withdraw approval of the drug by a Food...To view the full article, register now.
Already a subscriber? Click here to view full article